The FDA has issued a warning that compounded semaglutide may contain salt forms of semaglutide, such as semaglutide sodium or semaglutide acetate, instead of semaglutide base used in Ozempic and Wegovy
CJC-1295 Side Effects and Complications In clinical applications, CJC-1295 administration occassionally produces reactions at the injection site and a range of mild to moderate side effects, such as [15, 16]: Rapid heartbeat Headaches Abdominal discomfort Facial flushing Loose stools Nausea It is crucial to acknowledge that this peptide has not been authorized for human use by the United States Food and Drug Administration or comparable regulatory body, and its safety profile has not been extensively studied in large-scale clinical trials
The body can ingest many of the ingredients found in IV drip therapy, but it does so at a low and slow pace
In November 2023, the FDA added BPC-157 to its list of substances that cannot be used in compounding under the Federal Food, Drug, and Cosmetic Act, citing insufficient safety data for human use 3
Other problems include reduced blood flow to intestines, brain swelling, blood clotting defects, and impaired tissue oxygen delivery